Efficacy of transarterial chemoembolization prior to liver transplantation for hepatocellular carcinoma as found in pathology

Hepato-Gastroenterology

Volumn 52, Issue 62, 2005, Pages 329-332

  Sotiropoulos, Georgios C ^a   Malagó, Massimo ^a   Molmenti, Ernesto ^a   Paul, Andreas ^a   Nadalin, Silvio ^a   Brokalaki, Eirini I ^a   Verhagen, Rudiger ^a   Dirsch, Olaf ^a   Gerken, Guido ^a   Lang, Hauke ^a   Broelsch, Christoph E ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Bridging treatments; Hepatocellular carcinoma; Liver transplantation; TACE; Transarterial chemoembolization; Tumor staging

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CONTROL; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXPLANT; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LIVER TRANSPLANTATION; MORBIDITY; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; TUMOR REGRESSION;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; HUMANS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PREOPERATIVE CARE; TREATMENT OUTCOME;

EID: 20144389117     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. El Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340:745-750.
2. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699.
3. Sobin LH, Wittekind CH: TNM Classification of malignant tumours. Sixth edition. West Sussex: John Wiley & Sons, Ltd., 2002.
4. Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P, Weber JC, Audet M, Doffoel M, Wolf P: Small hepatocellular carcinoma in Child A cirrhotic patients: Hepatic resection versus transplantation. Liver Transpl 2003; 9:513-520.
5. Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, Fabregat J, Torras J: Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 2000; 190:580-587.
6. Gaiani S, Celli N, Cecilioni L, Piscaglia F, Bolondi L: Review article: percutaneous treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 2003; 17(Suppl 2):103-110.
7. Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W: Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9:557-563.
8. Puleo S, Mauro L, Gagliano G, Lombardo R, Li Destri G, Petrillo G, Di Carlo I: Liver damage after transarterial chemoembolization without embolizing agent in unresectable hepatocellular carcinoma. Tumori 2003; 89:285-287.
9. Stuart K: Chemoembolization in the management of liver tumors. Oncologist 2003; 8:425-437.
10. Testa R, Testa E, Giannini E, Botta F, Malfatti F, Chiarbonello B, Fumagalli A, Polegato S, Podesta E, Romagnoli P, Risso D, Cittadini G, De Caro G: Transcatheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment. Aliment Pharmacol Ther 2003; 17:1563-1569.
11. Donckier V, Van Laethem JL, Van Gansbeke D, Ickx B, Lingier P, Closset J, El Nakadi I, Feron P, Boon N, Bourgeois N, Adler M, Gelin M: New considerations for an overall approach to treat hepatocellular carcinoma in cirrhotic patients. J Surg Oncol 2003; 84:36-44.
12. Kitamoto M, Imagawa M, Yamada H, Watanabe C, Sumioka M, Satoh O, Shimamoto M, Kodama M, Kimura S, Kishimoto K, Okamoto Y, Fukuda Y, Dohi K: Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. Am J Roentgenol 2003; 181:997-1003.
13. Ochiai T, Sonoyama T, Hironaka T, Yamagishi H: Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma. Hepatogastroenterology 2003; 50:750-755.
14. Guo WJ, Yu EX, Liu LM, Li J, Chen Z, Lin JH, Meng ZQ, Feng Y: Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma. World J Gastroenterol 2003; 9:1697-1701.
15. Kaihara S, Kiuchi T, Ueda M, Oike F, Fujimoto Y, Ogawa K, Kozaki K, Tanaka K: Living-donor liver transplantation for hepatocellular carcinoma. Transplantation 2003; 75:837-40.
16. Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Dela Torre A, Cho KC, Contractor D, Korogodsky M: Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 2003; 197:759-764.
17. Maluf D, Fisher RA, Maroney T, Cotterell A, Fulcher A, Tisnado J, Contos M, Luketic V, Stravitz R, Shiffman M, Sterling R, Posner M: Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): Safety and efficacy. Am J Transplant 2003; 3:312-317.
18. Coad JE, Kosari K, Humar A, Sielaff TD: Radiofrequency ablation causes "thermal fixation" of hepatocellular carcinoma: a post-liver transplant histopathologic study. Clin Transplant 2003; 17:377-384.
19. Yamashiki N, Kato T, Bejarano PA, Berho M, Montalvo B, Shebert RT, Goodman ZD, Seki T, Schiff ER, Tzakis AG: Histopathological changes after microwave coagulation therapy patients with hepatocellular carcinoma: a review of 15 explanted livers. Am J Gastroenterol 2003; 98:2052-2059.